Related Experiment Video
Updated: May 23, 2025
13:21
Determining heat and mechanical pain threshold in inflamed skin of human subjects
Published on: January 14, 2009
20.8K
Buprenorphine's Effect on the Human Immune System and Inflammation
Samuel D Shin1, Rachel Branning2, Michele McGinnis3
1Department of Psychiatry and Psychology, Cleveland Clinic, Cleveland, Ohio, USA.
Clinical and Translational Science
|March 11, 2025
Summary
Buprenorphine treatment for opioid use disorder may restore immune function suppressed by the condition. This review highlights buprenorphine
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Opioid use disorder (OUD) is a major public health crisis.
- Inflammation's role in OUD pathogenesis is increasingly recognized.
- Buprenorphine is a leading medication for OUD treatment.
Purpose of the Study:
- To review current knowledge on buprenorphine's modulation of the immune system in OUD patients.
- To explore buprenorphine's effects on inflammatory functions in individuals with OUD.
Main Methods:
- A comprehensive literature review was performed across 11 major databases.
- 14 clinical studies were selected from 8177 initial records.
- Focus was on buprenorphine's impact on peripheral and central immune functions.
Main Results:
- Most studies indicate buprenorphine restores immune suppression associated with OUD.
- Buprenorphine positively affects peripheral immune system functions.
- Emerging research explores buprenorphine's central immune and inflammatory effects.
Conclusions:
- Buprenorphine appears to reverse opioid-induced immune deficits.
- Further research is needed to fully understand buprenorphine's neuroinflammatory effects.
- Buprenorphine shows promise in addressing both OUD and associated immune dysregulation.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
01:25Analgesia and Pain Management
420
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
420
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
203
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
203
01:20Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K